Lynch syndrome: The influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters

Familial Cancer

Volumn 9, Issue 3, 2010, Pages 357-363

  Blokhuis, M M ^a,b   Pietersen, G E ^a   Goldberg, P A ^c   Algar, U ^c   Van Der Merwe, L ^d,e,f   Mbatani, N ^c   Vorster, A A ^a   Ramesar, R S ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^e UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Environmental factors; Extracolonic cancers; Lynch Syndrome

Indexed keywords

PROTEIN MLH1;

ADULT; AGE; ARTICLE; BIRTH ORDER; BODY HEIGHT; BODY WEIGHT; BREAST CANCER; BREAST FEEDING; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ENVIRONMENTAL FACTOR; FEMALE; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HETEROZYGOTE; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; ORAL CONTRACEPTION; OVARY CANCER; PARITY; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH AFRICA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGE FACTORS; BODY MASS INDEX; BREAST FEEDING; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MENARCHE; MENOPAUSE; MUTATION; NEOPLASMS; NUCLEAR PROTEINS; PARITY; PEDIGREE; PREGNANCY; RISK FACTORS; SIBLINGS;

EID: 78650215962     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-010-9334-9     Document Type: Article

References (39)

1. Aarnio M, Sankila R, Pukkala E et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214-218
2. Amant F, Moerman P, Neven P et al (2005) Endometrial cancer. Lancet 366:491-505
3. Blokhuis MM, Goldberg PA, Pietersen GE et al (2008) The extracolonic cancer spectrum in females with the 'South African' hMLH1 c. C1528T mutation. Fam Cancer 7:191-198
4. Brohet RM, Goldgar DE, Easton DF et al (2007) Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS collaboration group. J Clin Oncol 25:3831-3836
5. Burn J, Bishop T, Mecklin JP et al (2008) Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med 359:2567-2578
6. Burn J, Mathers JC, Gerdes AM, et al. (2009) Cancer occurrence during follow-up of the CAPP2 study-aspirin use for up to 4 years significantly reduces Lynch syndrome cancers for up to 10 years. [cited 2009 Sept 07]. Available from: URL: http://www.capp2.com/newsZone/readnews.php?NewsID=45
7. Chang-Claude J, Andrie N, Rookus M et al (2007) Age at menarche and menopause and breast cancer risk in the international BRCA1/2 carrier cohort study. Cancer Epidemiol Biomarkers Prev 16:740-746
8. Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R et al (2008) Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23, 257 women with ovarian cancer and 87, 303 controls. Lancet 371:303-314
9. Cook LS, Weiss NS, Doherty JA (2006) Endometrial cancer. In: Schottenfeld D, Fraumeni JF et al (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 1027-1043
10. Diergaarde B, Braam H, Vasen HF et al (2007) Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 5:736-742
11. Dove-Edwin I, Boks D, Goff S et al (2002) The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 94:1708-1712
12. Dunlop MG, Farrington SM, Carothers AD et al (1997) Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6:105-110
13. Felix R, Bodmer W, Fearnhead NS et al (2006) GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutation. Mutat Res 602:175-181
14. Goecke T, Schulmann K, Engel C et al (2006) Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 24:4285-4292
15. Hankinson SE, Colditz GA, Willett WC (2004) Towards an integrated model for breast cancer etiology; the lifelong interplay of genes, lifestyle and hormones. Breast Cancer Res 6:213-218
16. Jäger AC, Bisgaard ML, Myrhoj T et al (1997) Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression. Am J Hum Genet 61:129-138
17. Järvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834
18. Lin KM, Shashidharan M, Ternent CA et al (1998) Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum 41:428-433
19. Lynch PM (2007) Prevention of colorectal cancer in high-risk populations: the increasing role for endoscopy and chemoprevention in FAP and HNPCC. Digestion 76:68-76
20. McLaughlin JR, Risch HA, Lubinski J et al (2007) Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet Oncol 8:26-34
21. Mokbel K (2003) Risk-reducing strategies for breast cancer-a review of recent literature. Int J Fertil Womens Med. 48:274-277
22. Narod SA, Risch H, Moslehi R et al (1998) Oral contraceptives and the risk of hereditary ovarian cancer: Hereditary Ovarian Clinical Study Group. N Engl J Med 339:424-428
23. Parc Y, Boisson C, Thomas G et al (2003) Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet 40:208-213
24. Peltomaki P, Gao X, Mecklin JP (2001) Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different versus shared predisposing mutations. Fam Cancer 1:9-15
25. Quehenberger F, Vasen HF, van Houwelingen HC (2005) Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42:491-496
26. Ramesar RS, Madden MV, Felix R et al (2000) Molecular genetics improves the management of hereditary non-polyposis colorectal cancer. S Afr Med J 90:709-714
27. Renkonen-Sinisalo L, Butzow R, Leminen A et al (2007) Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer 120:821-824
28. Rijcken FE, Mourits MJ, Kleibeuker JH et al (2003) Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 91:74-80
29. Smith A, Moran A, Boyd MC et al (2007) Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. J Med Genet 44:10-15
30. Stupart DA, Goldberg PA, Algar U, Ramesar RS (2009) Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation. Fam Cancer 8:519-523
31. Stupart DA, Goldberg PA, Algar U, Ramesar RS (2009) Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation. Colorectal Dis 11:126-130
32. Vasen HFA, Möslein G, Alonso A et al (2007) Guidelines for the clinical managment of Lynch syndrome (hereditaity non-polyposis cancer. J Med Genet 44:353-362
33. Vasen HFA, Stormorken A, Menko FH et al (2001) MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19:4074-4080
34. Vasen HF, Wijnen JT, Menko FH et al (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020-1027
35. Vasen HF, Watson P, Mecklin JP et al (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 116:1453-1456
36. Voskuil DW, Kampman E, Grubben MJ et al (2002) Meat consumption and meat preparation in relation to colorectal adenomas among sporadic and HNPCC family patients in The Netherlands. Eur J Cancer 38:2300-2308
37. Watson P, Ashwathnarayan R, Lynch HT et al (2004) Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). Arch Intern Med 164:2429-2431
38. Watson P, Riley B (2005) The tumor spectrum in the Lynch syndrome. Fam Cancer 4:245-248
39. No authors listed (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 347:1713-27